Table 3 Gene ontology analysis by strain in simulated microgravity compared to control.
Strain | Upregulated gene ontology biological process | P-value | FDR | Downregulated gene ontology biological process | P-value | FDR |
---|---|---|---|---|---|---|
All | DNA Metabolic Process | 4.6e−05 | 0.048 | Negative regulation of angiogenesis | 7.9e−06 | 0.012 |
 | Sarcomere organization | 0.0001 | 0.049 | Response to unfolded protein | 9.7e−06 | 0.012 |
 | Striated muscle contraction | 0.00013 | 0.049 | Telomere maintenance via telomerase | 0.00011 | 0.027 |
WSB/EiJ |  |  |  | Response to unfolded protein | 6e−09 | 1.3e−05 |
 |  |  |  | ‘de novo’ posttranslational protein folding | 5.2e−07 | 0.00056 |
 |  |  |  | Chaperone mediated protein folding requirement cofactor | 1.4e−06 | 0.001 |
PWK/PhJ | Cotranslational protein targeting to membrane | 3.2e−32 | 7.3e−29 | Actin-myosin filament sliding | 3.e−07 | 0.00029 |
 | Protein targeting to ER | 4.3e−30 | 3.2e−27 | Striated muscle contraction | 2.5e−06 | 0.0013 |
 | rRNA metabolic process | 6.1e−18 | 1.3e−15 | Glycogen catabolic process | 3.4e−06 | 0.0013 |
NZO/HILtJ | Striated muscle contraction | 1.9e−11 | 2.8e−08 | Negative regulation of cellular process | 2.5e−08 | 6.3e−05 |
 | Actin-myosin filament sliding | 1.4e−09 | 5.2e−07 | Extracellular matrix organization | 1.4e−06 | 0.0017 |
 | Sarcomere organization | 4.4e−08 | 1.4e−05 | Regulation of angiogenesis | 1e−05 | 0.0062 |
NOD/ShiLtJ |  |  |  | Negative regulation of transcription, DNA-templated | 1.7e−05 | 0.02 |
 |  |  |  | Myelination | 3.1e−05 | 0.024 |
 |  |  |  | Negative regulation of transcription from RNA polymerase II promoter | 9.6e−05 | 0.046 |
129S1/SvImJ |  |  |  | Positive regulation of cell differentiation | 1.2e−10 | 3.1e−07 |
 |  |  |  | Cellular amino acid catabolic process | 2.1e−09 | 2.8e−06 |
 |  |  |  | Regulation of cell migration | 1.5e−06 | 0.0005 |
CAST/EiJ | Muscle contraction | 3e−11 | 4.8e−08 | Extracellular matrix organization | 4.4e−12 | 8.9e−09 |
 | Actin-myosin filament sliding | 7.8e−11 | 4.8−08 | Peptide metabolic process | 3.2e−07 | 0.00027 |
 | Myofibril assembly | 8.3e−11 | 4.8e−08 | Collagen fibril organization | 3.9e−07 | 0.00027 |
C57BL/6J | Regulation of transcription from RNA polymerase II promoter | 5.5e−10 | 1.3e−06 | Respiratory chain complex IV assembly | 2.8e−05 | 0.022 |
 | RNA 3’ end processing | 2.5e−06 | 0.0018 | mRNA processing | 3.2e−05 | 0.022 |
 | Termination of RNA polymerase II transcription | 4.7e−05 | 0.016 | Polyamine biosynthetic process | 0.00029 | 0.074 |
A/J | SRP-dependent Cotranslational protein targeting to membrane | 5.8e−13 | 1.1e−09 | Cellular response to cytokine stimulus | 6.1e−24 | 1e−20 |
 | Peptide biosynthetic process | 8e−08 | 2.2e−05 | Cytokine-mediated signaling pathway | 7.4e24 | 1e−20 |
 | Translation | 1.7e−06 | 0.00032 | Positive regulation of transcription from RNA polymerase II promoter | 3.5e−12 | 2.5e−09 |